Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Sibutramine Hydrochloride Solution, 1.0 mg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco S0111ML
Description
Sibutramine, a SNRI and anorectant, was marketed as a treatment for obesity until 2010 when it was removed from the market over concerns of potential adverse cardiovascular side effects. Sold under trade names Reductil, Meridia™, and Subitrex, this sibutramine Snap-N-Spike™ reference solution is applicable for use in LC/MS or GC/MS applications for clinical toxicology and forensic analysis.
Specifications
| 67-56-1, 84485-00-7 | |
| MFCD04039806 | |
| 1.0 mg/mL in methanol (as free base) | |
| 316.31 | |
| 1 mL |
| C17H26ClN · HCl | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| Sibutramine hydrochloride monohydrate, 1-(4-Chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)cyclobutanemethanamine hydrochloride monohydrate, Meridia, Reductil | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
CERILLIANT is a registered trademark of Cerilliant Corporation
Spot an opportunity for improvement?Share a Content Correction